TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›MCBS›Financials
Annual statements · SEC XBRL · FY2017 – FY2025

MetroCity Bankshares, Inc. (MCBS) financials

Income statement

MetroCity Bankshares, Inc. (MCBS) income statement, annual, from SEC filings
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income$31.9M$41.3M$44.7M$36.4M$61.7M$62.6M$51.6M$64.5M$68.5M
EPS (diluted)$1.32$1.69$1.81$1.41$2.39$2.44$2.02$2.52$2.64

Cash flow

MetroCity Bankshares, Inc. (MCBS) cash flow, annual, from SEC filings
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$152M-$161M$32.2M$143M$65.4M$135M$82.1M$63.5M$37.7M
Capital expenditures$5.91M$2.85M$1.10M$537K$384K$2.35M$4.93M$1.29M$674K
Free cash flow$146M-$164M$31.1M$142M$65.0M$132M$77.2M$62.2M$37.0M
Share buybacks——$1.49M—$5.54M$8.20M$2.02M$10.0K$2.73M
Dividends paid$5.40M$9.29M$10.4M$10.3M$11.8M$15.3M$18.2M$21.1M$24.8M

Balance sheet

MetroCity Bankshares, Inc. (MCBS) balance sheet, annual, from SEC filings
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$95.8M$138M$276M$151M$441M$179M$145M$250M$384M
Total assets—$1.43B$1.63B$1.90B$3.11B$3.43B$3.50B$3.59B$4.77B
Total liabilities—$1.26B$1.42B$1.65B$2.82B$3.08B$3.12B$3.17B$4.22B
Shareholders' equity$135M$169M$217M$245M$290M$349M$382M$421M$544M
Retained earnings—$129M$163M$189M$239M$286M$315M$359M$403M
Shares (wtd avg diluted)24.1M24.5M24.7M25.8M25.8M25.7M25.5M25.6M26.0M

Every figure is extracted from MetroCity Bankshares, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is MetroCity Bankshares, Inc.'s free cash flow?
$37.0M in FY2025 (operating cash flow $37.7M minus $674K of capital expenditures), from the SEC cash-flow statement.
Does MCBS pay a dividend?
Yes — MetroCity Bankshares, Inc. paid $24.8M in cash dividends during FY2025, per its SEC cash-flow statement.
Full MCBS analysis — verdict, score & filings →Is MCBS a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.